Manatuck Hill Partners’s Boston Scientific BSX Stock Holding History

Manatuck Hill Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$799K	Hold	12,738	–	–	0.22%	88
2025 Q4	$1.21M	Hold	12,738	–	–	0.43%	54
2025 Q3	$1.24M	Hold	12,738	–	–	0.41%	66
2025 Q2	$1.37M	Hold	12,738	–	–	0.52%	62
2025 Q1	$1.29M	Hold	12,738	–	–	0.59%	53
2024 Q4	$1.14M	Hold	12,738	–	–	0.47%	57
2024 Q3	$1.07M	Hold	12,738	–	–	0.39%	66
2024 Q2	$981K	Hold	12,738	–	–	0.41%	64
2024 Q1	$872K	Hold	12,738	–	–	0.38%	66
2023 Q4	$736K	Hold	12,738	–	–	0.31%	77
2023 Q3	$673K	Hold	12,738	–	–	0.3%	78
2023 Q2	$689K	Hold	12,738	–	–	0.33%	65
2023 Q1	$637K	Hold	12,738	–	–	0.32%	60
2022 Q4	$589K	Hold	12,738	–	–	0.28%	67
2022 Q3	$493K	Hold	12,738	–	–	0.25%	65
2022 Q2	$475K	Hold	12,738	–	–	0.24%	64
2022 Q1	$564K	Hold	12,738	–	–	0.22%	78
2021 Q4	$541K	Hold	12,738	–	–	0.2%	78
2021 Q3	$553K	Hold	12,738	–	–	0.19%	82
2021 Q2	$545K	Buy	+12,738	New	+$536K	0.16%	96
2021 Q1	–	Sell	-12,738	Closed	-$458K	–	113
2020 Q4	$458K	Hold	12,738	–	–	0.18%	77
2020 Q3	$487K	Hold	12,738	–	–	0.22%	81
2020 Q2	$447K	Hold	12,738	–	–	0.26%	63
2020 Q1	$416K	Hold	12,738	–	–	0.38%	53
2019 Q4	$576K	Hold	12,738	–	–	0.3%	72
2019 Q3	$518K	Hold	12,738	–	–	0.28%	64
2019 Q2	$547K	Hold	12,738	–	–	0.26%	78
2019 Q1	$489K	Hold	12,738	–	–	0.23%	77
2018 Q4	$450K	Hold	12,738	–	–	0.23%	72
2018 Q3	$490K	Hold	12,738	–	–	0.18%	70
2018 Q2	$417K	Hold	12,738	–	–	0.17%	74
2018 Q1	$348K	Hold	12,738	–	–	0.18%	66
2017 Q4	$316K	Hold	12,738	–	–	0.16%	67
2017 Q3	$372K	Hold	12,738	–	–	0.18%	65
2017 Q2	$353K	Hold	12,738	–	–	0.18%	66
2017 Q1	$317K	Hold	12,738	–	–	0.14%	73
2016 Q4	$276K	Hold	12,738	–	–	0.14%	69
2016 Q3	$303K	Hold	12,738	–	–	0.12%	78
2016 Q2	$298K	Hold	12,738	–	–	0.13%	70
2016 Q1	$240K	Hold	12,738	–	–	0.09%	77
2015 Q4	$235K	Hold	12,738	–	–	0.08%	68
2015 Q3	$209K	Hold	12,738	–	–	0.09%	59
2015 Q2	$225K	Hold	12,738	–	–	0.07%	71
2015 Q1	$226K	Hold	12,738	–	–	0.06%	81
2014 Q4	$169K	Hold	12,738	–	–	0.04%	79
2014 Q3	$150K	Hold	12,738	–	–	0.03%	89
2014 Q2	$163K	Hold	12,738	–	–	0.03%	85
2014 Q1	$172K	Hold	12,738	–	–	0.03%	103
2013 Q4	$153K	Hold	12,738	–	–	0.02%	85
2013 Q3	$150K	Hold	12,738	–	–	0.02%	93
2013 Q2	$118K	Buy	+12,738	New	+$108K	0.01%	88

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manatuck Hill Partners's BSX Position: Q1 2026 in Review

Manatuck Hill Partners held its Boston Scientific (BSX) position steady in Q1 2026 at 12,738 shares worth $799K. The position accounts for 0.22% of the portfolio, ranked #88.

Manatuck Hill Partners first reported a position in BSX in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.37M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Manatuck Hill Partners held 12,738 shares of Boston Scientific worth $799K as of Q1 2026.
Manatuck Hill Partners left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up 0.22% of Manatuck Hill Partners's portfolio in Q1 2026, its #88 holding.
Manatuck Hill Partners first reported a position in Boston Scientific in Q2 2013 and has held it in 51 quarters since.
Manatuck Hill Partners's Boston Scientific position peaked at $1.37M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Manatuck Hill Partners's 13F filing for Q1 2026, filed 15 May 2026.